|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02407 GAUSH MEDITECH
Nominal 
10.740 -0.420 (-3.763%) Ranking Overview
Ranking based on 1 research report(s)
Average Ranking 3.00
|
Strong Buy (1)
0
|
Buy (2)
0
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 117.00 RMB (cts) | |
| Net Profit | 173.52 RMB (MIL) | DPS | 99.77 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 98.55 | 67.00 | -- | 98.55 | 98.55 | |
| 2025 | 166.34 | 112.00 | -- | 166.34 | 166.34 | |
| 2026 | 209.10 | 141.00 | -- | 209.10 | 209.10 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 98.55 | 67.00 | -- | MORGAN STANLEY | Equal-weight | 15.60 | 18/07/2024 | |
| 2025 | 166.34 | 112.00 | -- | MORGAN STANLEY | -- | -- | 18/07/2024 | |
| 2026 | 209.10 | 141.00 | -- | MORGAN STANLEY | -- | -- | 18/07/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 28/11/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 28,474,000 |
| %Change | -74.416% |
| EPS / (LPS) | RMB 0.190 |
| NBV Per Share (¥) | RMB 10.411 |